中文 | English
Return
Total: 24 , 1/3
Show Home Prev Next End page: GO
Author:(Xueguan LU)

1.Adjuvant chemoradiotherapy for postoperative head and neck squamous cell carcinoma

Xueguan LU ; Chaosu HU

China Oncology 2017;27(6):463-470

2.Research progression of microenviroment hypoxia influencing DNA damage-repair in tumour cells

Liumei TONG ; Libo FENG ; Xueguan LU

Journal of International Oncology 2009;36(11):812-814

3.Advances in research on ATM as a target for novel radiosensitizers

Jinsong YANG ; Xueguan LU ; Yan FENG

China Oncology 2001;0(02):-

4.Prognostic factors of rectal cancer treated with multimodality therapy based on surgery

Chong DENG ; Xueguan LU ; Ye TIAN

Chinese Journal of Clinical Pharmacology and Therapeutics 2004;0(07):-

5.Preliminary study on prediction of radiosensitivity of human tumor cells with fluorescence in situ hybridization

Shun WANG ; Xueguan LU ; Chaosu HU

Chinese Journal of Radiation Oncology 1992;0(01):-

6.Radiation treatment of 60 patients with cervical lymph node metastatic squamous cell carcinoma from an unknown primary site.

Xueguan LU ; Yan FENG ; Chaosu HU

Chinese Journal of Radiation Oncology 1992;0(04):-

8.Radiation therapy 45 patients with prostate carcinoma

Yunhai LI ; Xueguan LU ; Ziqiang PAN ; Yan FENG

Chinese Journal of Radiation Oncology 1992;0(01):-

9.Relation between mutation of DNA-Ligase Ⅳ gene and radiosensitivity in human nasopharyngeal carcinoma cell lines

Shun WANG ; Xueguan LU ; Weijian ZHANG ; Chaosu HU ; Yan FENG

Chinese Journal of Radiation Oncology 1995;0(02):-

10.mRNA expression of HIF-1? and VEGF genes in nasopharyngeal squamous cell line cells during hypoxia-reoxygenation

Xueguan LU ; Shun WANG ; Chaosu HU ; Yan FENG

Chinese Journal of Radiation Oncology 1993;0(03):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 24 , 1/3 Show Home Prev Next End page: GO